FindTrial
Sign In

Removal of harmful bacteria from nose

Eradication of nasal staphylococcus aureus by phage therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018476
Enrollment
30
Registered
2019-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NOT APPLICABLE: NOT APPLICABLE Control Intervention1: not applicable: not applicable

Sponsors

UGC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: healthy carrier of staphylococcus aureus

Exclusion criteria

Exclusion criteria: age below 16 years abd above 65 years, any sickness

Design outcomes

Primary

MeasureTime frame
eradication of nasal staph aureusTimepoint: on day 15th, 30th and 60th—

Secondary

MeasureTime frame
Reduction in bacterial countTimepoint: on day 15th—

Countries

India

Contacts

Public ContactPOOJA GUPTA

BANARAS HINDU UNIVERSITY

gopalnath@gmail.com9335058394

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026